CNS Tumors
Showing 1 - 25 of >10,000
CNS Germinoma, CNS Tumor, Asian Consortium Trial in Goyang-si (Radiation Therapy)
Recruiting
- CNS Germinoma
- +2 more
- Radiation Therapy
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center, Korea
Aug 7, 2023
Artificial Intelligence in CNS Radiation Oncology
Not yet recruiting
- CNS Tumor
- The images (CT, MRI, PET) used for RT planning, mid-treatment imaging as part of IGRT or disease evaluation, and response assessment/ surveillance post-RT
- (no location specified)
Sep 6, 2023
CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)
Not yet recruiting
- Central Nervous System Neoplasms
- +6 more
- B7-H3-CAR T cells
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 18, 2023
68-Ga DOTATATE PET/MRI in Diagnosis and Management of
Recruiting
- CNS Tumors
- +6 more
- Ga68-DOTATATE-PET/MRI
-
New York, New YorkWeill Cornell Medicine
Sep 20, 2022
Brain Slice Explants to Predict Drug Response in Brain Tumors
Not yet recruiting
- Central Nervous System Tumor
- Biospecimen collection
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 28, 2023
Rare CNS Tumors Outcomes &Risk
Recruiting
- High Grade Meningioma
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jul 6, 2022
Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)
Recruiting
- Ewing's Family Tumors
- +11 more
- Ifosfamide
- +13 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,
Not yet recruiting
- Rhabdoid Tumor
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 11, 2023
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)
Recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- HER2-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of
Recruiting
- Diffuse Midline Glioma (DMG)
- +7 more
- ONC206
- Standard of Care Radiation Therapy
-
San Francisco, California
- +2 more
Sep 13, 2022
CNS Tumors Trial in Worldwide (Avelumab, Lenvatinib)
Recruiting
- Central Nervous System Tumors
-
Saint Louis, Missouri
- +9 more
Jul 21, 2022
Three-Factor Eating Questionnaire in Measuring Eating Behavior
Completed
- Cancer Survivor
- Nutritional Assessment
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,
Not yet recruiting
- Anaplastic Astrocytoma
- +17 more
- (no location specified)
Jun 28, 2023
Advanced Non CNS Tumors Trial in Worldwide (Talimogene Laherparepvec)
Completed
- Advanced Non CNS Tumors
- Talimogene Laherparepvec
-
Wilmington, Delaware
- +21 more
Dec 21, 2022
ALK Fusion-positive Solid or CNS Tumors Trial in Worldwide (Alectinib)
Recruiting
- ALK Fusion-positive Solid or CNS Tumors
-
New York, New York
- +17 more
Jul 25, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- SC-CAR4BRAIN
-
Seattle, WashingtonSeattle Children's Hospital
Mar 3, 2023
CNS Qualitative Interview
Recruiting
- Central Nervous System Cancer
- Qualitative Interviews
-
Aurora, ColoradoChildren's Hospital Colorado
Oct 31, 2022
Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)
Not yet recruiting
- Advanced Solid Tumor
- +2 more
-
Palo Alto, California
- +9 more
Aug 2, 2022
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)
Recruiting
- Ewing Sarcoma
- +5 more
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
Germ Cell Tumors of the Central Nervous System
Recruiting
- Germ Cell Tumor of CNS
-
Beijing, ChinaSanbo Brain Hospital Capital Medical University
Apr 19, 2023
Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant
Recruiting
- Atypical Teratoid Rhabdoid Tumor
- +6 more
- Tazemetostat
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 23, 2023
Nervous System Tumor Trial (Administration of Indocyanine Green (ICG) and Visualization of Tumor)
Not yet recruiting
- Nervous System Tumor
- Administration of Indocyanine Green (ICG) and Visualization of Tumor
- (no location specified)
Feb 17, 2023